2025. Impact of Severity and Disease Course on Baricitinib Treatment Response in Adolescent Patients with Severe AA from the BRAVE-AA-PEDS Trial. SKIN The Journal of Cutaneous Medicine. 9, 6 (Nov. 2025), s665. DOI:https://doi.org/10.25251/0fqz5v46.